Who is the CEO of Phytochem Remedies India Ltd?
- Answer Field
-
DR.P.Sreemannarayana is the Chairman of the company, whereas MR.Y.Nayudamma is the Managing Director.
Phytochem Remedies (India) Limited is engaged in manufacturing corrugated boxes and board-based packaging solutions for sectors such as food and beverages, FMCG, pesticides, pharmaceuticals, and automotive. The company operates from two units in Jammu and has gradually expanded its capabilities since commencing manufacturing operations. Its activities focus on supplying customised packaging products, supported by a network that serves clients across different regions. The company’s position in the corrugated packaging space is shaped by its product range, operational footprint, and the nature of industries it caters to.
Investors who wish to participate in the IPO can apply through online or offline methods provided by their brokerage platform or bank offering ASBA facilities. The online application process typically includes logging in to the investor’s trading or banking account, selecting the IPO section, entering bid details, and confirming the application using the available payment authorisation mechanism. For those applying through the ASBA route, the process generally involves submitting an application via net banking and selecting the IPO under the invest section, after which the application amount remains blocked until allotment.
For more details, visit the Gujarat Kidney & Super Speciality Limited IPO page.
Details | Information |
IPO Date | December 18, 2025 to December 22, 2025 |
Issue Size | 39,00,000 shares (aggregating up to ₹38.22 Cr) |
Price Band | ₹98 per share |
Lot Size | 1200 shares |
Listing At | BSE, SME |
Market Maker | Aftertrade Broking Pvt.Ltd. |
Funding capital expenditure requirements for the purchase of equipment/machineries
Funding capital expenditure requirements towards civil construction
Repayment/pre-payment, in full or in part, of certain borrowings availed by the Company
General Corporate Purposes
Event | Date |
|---|---|
IPO Open Date | Thu, Dec 18, 2025 |
IPO Close Date | Mon, Dec 22, 2025 |
Tentative Allotment | Tue, Dec 23, 2025 |
Initiation of Refunds | Wed, Dec 24, 2025 |
Credit of Shares to Demat | Wed, Dec 24, 2025 |
Tentative Listing Date | Fri, Dec 26, 2025 |
Cut-off time for UPI mandate confirmation | 5 PM on Mon, Dec 22, 2025 |
₹98 per share
Minimum Lot Size and Application Details
Application | Lots | Shares | Amount |
Individual investors (Retail) (Min) | 2 | 2,400 | ₹2,35,200 |
Individual investors (Retail) (Max) | 2 | 2,400 | ₹2,35,200 |
HNI (Min) | 3 | 3,600 | ₹3,52,800 |
The Gujarat Kidney & Super Speciality Limited IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:
Access your trading account using the broker's app or website.
Go to the IPO section to view active IPO listings.
Locate Gujarat Kidney & Super Speciality Limited IPO in the list of available IPOs and click the ‘Apply’ button.
Specify the number of shares (lot size: 1200 shares) within the price band of ₹98 per share.
Enter your UPI ID for payment authorisation and ensure sufficient funds in your bank account.
Review your application details and confirm the UPI mandate before 5 PM on the last application day.
Submit the application and monitor the allotment status to check if shares have been allocated to you.
Total Assets: Grew from ₹37.07 crore in FY23 to ₹53.68 crore as of Sept 2025.
Total income: Reached ₹25.01 crore in FY25, as compared to ₹20.83 crore in FY23.
Profit After Tax (PAT): Stood at ₹3.75 crore for Sept 2025 as compared to ₹0.82 crore in FY23.
Net Worth: Recorded at ₹16.89 crore in FY25 in comparison to ₹6.42 crore in FY23.
Reserves and surplus: Stood at ₹9.02 crore in FY25, as compared to ₹3.20 crore in FY23.
EBITDA: Stood at ₹6.72 crore in Sept 2025 in comparison to ₹2.91 crore in FY23.
The company has recorded steady expansion in its asset base over the review period.
Its overall income has shown an upward trend, reflecting increased operational activity.
Profitability has improved compared with earlier years, indicating better cost and revenue management.
The organisation has strengthened its financial position, with growth observed in its net worth.
Reserves have expanded over time, supporting future operational and developmental plans.
Operating performance has progressed, with higher earnings generated from core business activities.
The company operates in a sector that may be influenced by fluctuations in demand from industries it supplies to, which could affect its operational stability.
Expansion plans and capital expenditure activities may expose the organisation to factors such as project timelines, execution challenges, and availability of resources.
The company’s presence across multiple industries offers scope to serve a diversified customer base, which may support long-term operational continuity.
Ongoing development of its facilities and network may allow the company to strengthen its reach and broaden its product offerings over time.
| KPI | Values |
| ROE | 34.07% |
| ROCE | 25.29% |
| Debt/Equity | 1.42 |
| RoNW | 34.07% |
| PAT Margin | 12.25% |
| EBITDA Margin | 23.78% |
| Price to Book Value | 2.35 |
Registrar | Lead Manager(s) |
|---|---|
Bigshare Services Pvt.Ltd. | Mefcom Capital Markets Ltd. |
Phytochem Remedies (India) Ltd. Address
220,
Ashok Nagar Main Road,
Udaipur City, Girwa,
Udaipur, Rajasthan, 313001
Phone: +91 294 4577549
Email: cs@phytochem.co.in
Website: http://www.phytochem.co.in/
The IPO details present an overview of the company’s objectives, operational activities, and financial information, allowing readers to understand its background and the purpose behind the issue. The application process, timelines, pricing information, and procedural steps offer clarity on how interested participants can submit their bids through available online platforms.
The concluding assessment reflects the organisation’s current position, recent performance trends, and the factors that may influence its operations. Readers can use this information to form their own understanding of the company’s profile and the structure of the IPO based on the disclosures provided.
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Gujarat Kidney & Super Speciality IPO allotment status.
No result found
DR.P.Sreemannarayana is the Chairman of the company, whereas MR.Y.Nayudamma is the Managing Director.
Phytochem Remedies (India) Limited is engaged in the manufacture of corrugated packaging products, including boxes, sheets, rolls, and pads, serving sectors such as pharmaceuticals, agriculture, FMCG and automotive. Its operations are conducted from manufacturing facilities in Jammu, with production tailored to order requirements. The sustainability of the business model in the long term depends on ongoing demand for packaging solutions, operational practices, supply chain management and the company’s ability to meet regulatory and customer quality expectations.
The issue comprises a fixed price offering of 39,00,000 equity shares aggregating up to ₹38.22 crore. This represents the total number of shares being offered for subscription as per the issue details published on verified IPO platforms.
‘Pre-apply’ refers to submitting an IPO application before the official opening date. When a platform allows pre-application, the investor’s bid is recorded and then formally processed once the subscription period begins. This feature is generally offered by trading apps and banks to help applicants prepare in advance.
The IPO’s lot size has been defined as 1,200 shares per application. The minimum market lot for retail investors is two lots, equivalent to 2,400 shares, with allotments processed according to exchange rules for SME issues.
Based on the IPO timetable published for this issue, the basis of allotment is expected to be determined on December 23, 2025. This is the date when applications are reviewed and share allocations are finalised as per regulatory norms.
The registrar for the Phytochem Remedies (India) IPO is Bigshare Services Pvt. Ltd. The registrar manages administrative tasks related to the IPO, including record keeping, processing allotments, refunds and communication with investors.
There are no specific governance issues or red flags mentioned in the publicly available IPO details. Any assessment of governance standards and board composition should be based on disclosures in the Draft Red Herring Prospectus (DRHP) and final offer documents filed with the regulator and stock exchanges.
To apply for the IPO, investors can use an online trading account or bank net banking through the ASBA (Application Supported by Blocked Amount) process. The application generally involves selecting the IPO from the list of active issues, entering the desired number of lots within the allowed price band, providing payment authorisation, and submitting before the subscription closing date.
Yes, a Demat account is required to apply for the Phytochem Remedies IPO, as allotted shares are credited electronically to the investor’s Demat account. Applications without a valid Demat account cannot be processed.
After the basis of allotment is finalised, the allotment status can be checked through the IPO registrar’s website or the trading platform used to submit the application. The status will indicate whether shares have been allocated, and any refunds due will be processed as per exchange timelines.
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading